We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

News   Oct 19, 2017 | Original Story from Oak Ridge National Laboratory

 
Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

An ORNL-led team used neutrons to observe the AAT enzyme, a vitamin B6-dependent protein, and found that the chemical reaction occurred only in one active site. Nuclear scattering length density maps (colored mesh) highlight the positions of critical hydrogen atoms, including a low-barrier hydrogen bond (magenta mesh) not thought to exist in AAT, which may be crucial for catalysis. Credit: Jill Hemman and Andrey Kovalevsky /Oak Ridge National Laboratory, US Dept. of Energy.

 
 
 

RELATED ARTICLES

Existing Drugs Could Be Key To Combatting Coronavirus Outbreak

News

Developing new drugs and vaccines to treat the coronavirus that causes COVID-19 can take years. Existing drugs may offer a possible quick response to the potential pandemic.

READ MORE

Breast and Kidney Cancer Drug Could Also Help Patients With Advanced Head and Neck Cancer

News

A targeted therapy drug already used for breast and kidney cancers may also extend progression-free survival of patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.

READ MORE

Preventing Aggressive Tumors From Becoming Resistant to Chemotherapy

News

CDK4/6 inhibitors are effective in certain types of cancer but they cannot be used together with chemotherapy. Now researchers have changed their approach to using CDK4/6 inhibitors – by administering them after chemotherapy. This strategy prevents tumor cells of pancreatic adenocarcinoma from recovering from the damage caused by chemotherapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE